We are a team of scientific, medical, financial, technological, and operational leaders built to serve our partners
Our deep understanding of subsector-specific scientific, regulatory, and commercial dynamics underpins everything we do.
Paul Sekhri
Petrichor Operating Partner
+
Paul Sekhri
Petrichor Operating Partner
Mr. Sekhri is a highly accomplished executive with over 35 years of leadership experience across the global life sciences industry. His career spans senior operating roles in multinational pharmaceutical companies, venture-backed biotech firms, and top-tier venture capital and private equity organizations.
Mr. Sekhri currently serves as Chairman, President, and Chief Executive Officer of vTv Therapeutics, Inc. Previously, he was President and CEO of eGenesis, Inc., where he led significant scientific and organizational advancements in xenotransplantation. Earlier roles include President and CEO at Lycera Corporation, a biopharmaceutical company focused on immune-mediated diseases, and Founder, President and CEO at Cerimon Pharmaceuticals, where he built the company from inception and led multiple product development initiatives. Additionally, Mr. Sekhri has held senior business development and strategy roles at Sanofi, Teva Pharmaceutical Industries, Ltd., TPG Biotech, ARIAD Pharmaceuticals, and Novartis AG.
Mr. Sekhri has served on more than 40 public and private company boards. He currently serves on the boards at Veeva Systems Inc., Kayothera Inc., and Deep Genomics, Inc. He is also Chairman of the Board at Resolution Therapeutics Ltd., and Executive Chairman of Violet Therapeutics, Inc. Beyond the life sciences sector, Mr. Sekhri is deeply engaged in the arts. He serves as Chairman of the Board of Young Concert Artists, is a member of the Advisory Council of the New York Philharmonic and previously served on the Board of the Metropolitan Opera.
Paul Sekhri
Petrichor Operating Partner
Mr. Sekhri is a highly accomplished executive with over 35 years of leadership experience across the global life sciences industry. His career spans senior operating roles in multinational pharmaceutical companies, venture-backed biotech firms, and top-tier venture capital and private equity organizations.
Mr. Sekhri currently serves as Chairman, President, and Chief Executive Officer of vTv Therapeutics, Inc. Previously, he was President and CEO of eGenesis, Inc., where he led significant scientific and organizational advancements in xenotransplantation. Earlier roles include President and CEO at Lycera Corporation, a biopharmaceutical company focused on immune-mediated diseases, and Founder, President and CEO at Cerimon Pharmaceuticals, where he built the company from inception and led multiple product development initiatives. Additionally, Mr. Sekhri has held senior business development and strategy roles at Sanofi, Teva Pharmaceutical Industries, Ltd., TPG Biotech, ARIAD Pharmaceuticals, and Novartis AG.
Mr. Sekhri has served on more than 40 public and private company boards. He currently serves on the boards at Veeva Systems Inc., Kayothera Inc., and Deep Genomics, Inc. He is also Chairman of the Board at Resolution Therapeutics Ltd., and Executive Chairman of Violet Therapeutics, Inc. Beyond the life sciences sector, Mr. Sekhri is deeply engaged in the arts. He serves as Chairman of the Board of Young Concert Artists, is a member of the Advisory Council of the New York Philharmonic and previously served on the Board of the Metropolitan Opera.